The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Gene Therapy in Oncology Market Research Report 2025

Global Gene Therapy in Oncology Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1718533

No of Pages : 107

Ask Your Query
Synopsis
Gene therapy refers to any procedure that aims to treat or alleviate a disease by genetically modifying the cell of a patient. 
The global Gene Therapy in Oncology market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Gene Therapy in Oncology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy in Oncology.
Report Scope
The Gene Therapy in Oncology market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gene Therapy in Oncology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Therapy in Oncology companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bristol-Myers Squibb
Cold Genesys
Advantagene
Amgen
AstraZeneca
Bio-Path Holdings
CRISPR Therapeutics
Editas Medicine
Geron Corp
Idera Pharmaceuticals
Intellia Therapeutics
Johnson & Johnson
Marsala Biotech
Merck
Mologen AG
Oncolytics Biotech
Oncosec
Oncotelic
Shenzhen SiBiono GeneTech
Sillajen BiOthersapeutics
Tocagen
UniQure
Ziopharm Oncology
Segment by Type
Ex Vivo
In Vivo
Segment by Application
Hospitals
Diagnostics Centers
Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gene Therapy in Oncology companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy in Oncology Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Ex Vivo
1.2.3 In Vivo
1.3 Market by Application
1.3.1 Global Gene Therapy in Oncology Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostics Centers
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy in Oncology Market Perspective (2019-2030)
2.2 Gene Therapy in Oncology Growth Trends by Region
2.2.1 Global Gene Therapy in Oncology Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Gene Therapy in Oncology Historic Market Size by Region (2019-2024)
2.2.3 Gene Therapy in Oncology Forecasted Market Size by Region (2025-2030)
2.3 Gene Therapy in Oncology Market Dynamics
2.3.1 Gene Therapy in Oncology Industry Trends
2.3.2 Gene Therapy in Oncology Market Drivers
2.3.3 Gene Therapy in Oncology Market Challenges
2.3.4 Gene Therapy in Oncology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy in Oncology Players by Revenue
3.1.1 Global Top Gene Therapy in Oncology Players by Revenue (2019-2024)
3.1.2 Global Gene Therapy in Oncology Revenue Market Share by Players (2019-2024)
3.2 Global Gene Therapy in Oncology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gene Therapy in Oncology Revenue
3.4 Global Gene Therapy in Oncology Market Concentration Ratio
3.4.1 Global Gene Therapy in Oncology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy in Oncology Revenue in 2023
3.5 Gene Therapy in Oncology Key Players Head office and Area Served
3.6 Key Players Gene Therapy in Oncology Product Solution and Service
3.7 Date of Enter into Gene Therapy in Oncology Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy in Oncology Breakdown Data by Type
4.1 Global Gene Therapy in Oncology Historic Market Size by Type (2019-2024)
4.2 Global Gene Therapy in Oncology Forecasted Market Size by Type (2025-2030)
5 Gene Therapy in Oncology Breakdown Data by Application
5.1 Global Gene Therapy in Oncology Historic Market Size by Application (2019-2024)
5.2 Global Gene Therapy in Oncology Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Gene Therapy in Oncology Market Size (2019-2030)
6.2 North America Gene Therapy in Oncology Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Gene Therapy in Oncology Market Size by Country (2019-2024)
6.4 North America Gene Therapy in Oncology Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapy in Oncology Market Size (2019-2030)
7.2 Europe Gene Therapy in Oncology Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Gene Therapy in Oncology Market Size by Country (2019-2024)
7.4 Europe Gene Therapy in Oncology Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy in Oncology Market Size (2019-2030)
8.2 Asia-Pacific Gene Therapy in Oncology Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Gene Therapy in Oncology Market Size by Region (2019-2024)
8.4 Asia-Pacific Gene Therapy in Oncology Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Therapy in Oncology Market Size (2019-2030)
9.2 Latin America Gene Therapy in Oncology Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Gene Therapy in Oncology Market Size by Country (2019-2024)
9.4 Latin America Gene Therapy in Oncology Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy in Oncology Market Size (2019-2030)
10.2 Middle East & Africa Gene Therapy in Oncology Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Gene Therapy in Oncology Market Size by Country (2019-2024)
10.4 Middle East & Africa Gene Therapy in Oncology Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bristol-Myers Squibb
11.1.1 Bristol-Myers Squibb Company Detail
11.1.2 Bristol-Myers Squibb Business Overview
11.1.3 Bristol-Myers Squibb Gene Therapy in Oncology Introduction
11.1.4 Bristol-Myers Squibb Revenue in Gene Therapy in Oncology Business (2019-2024)
11.1.5 Bristol-Myers Squibb Recent Development
11.2 Cold Genesys
11.2.1 Cold Genesys Company Detail
11.2.2 Cold Genesys Business Overview
11.2.3 Cold Genesys Gene Therapy in Oncology Introduction
11.2.4 Cold Genesys Revenue in Gene Therapy in Oncology Business (2019-2024)
11.2.5 Cold Genesys Recent Development
11.3 Advantagene
11.3.1 Advantagene Company Detail
11.3.2 Advantagene Business Overview
11.3.3 Advantagene Gene Therapy in Oncology Introduction
11.3.4 Advantagene Revenue in Gene Therapy in Oncology Business (2019-2024)
11.3.5 Advantagene Recent Development
11.4 Amgen
11.4.1 Amgen Company Detail
11.4.2 Amgen Business Overview
11.4.3 Amgen Gene Therapy in Oncology Introduction
11.4.4 Amgen Revenue in Gene Therapy in Oncology Business (2019-2024)
11.4.5 Amgen Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Detail
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Gene Therapy in Oncology Introduction
11.5.4 AstraZeneca Revenue in Gene Therapy in Oncology Business (2019-2024)
11.5.5 AstraZeneca Recent Development
11.6 Bio-Path Holdings
11.6.1 Bio-Path Holdings Company Detail
11.6.2 Bio-Path Holdings Business Overview
11.6.3 Bio-Path Holdings Gene Therapy in Oncology Introduction
11.6.4 Bio-Path Holdings Revenue in Gene Therapy in Oncology Business (2019-2024)
11.6.5 Bio-Path Holdings Recent Development
11.7 CRISPR Therapeutics
11.7.1 CRISPR Therapeutics Company Detail
11.7.2 CRISPR Therapeutics Business Overview
11.7.3 CRISPR Therapeutics Gene Therapy in Oncology Introduction
11.7.4 CRISPR Therapeutics Revenue in Gene Therapy in Oncology Business (2019-2024)
11.7.5 CRISPR Therapeutics Recent Development
11.8 Editas Medicine
11.8.1 Editas Medicine Company Detail
11.8.2 Editas Medicine Business Overview
11.8.3 Editas Medicine Gene Therapy in Oncology Introduction
11.8.4 Editas Medicine Revenue in Gene Therapy in Oncology Business (2019-2024)
11.8.5 Editas Medicine Recent Development
11.9 Geron Corp
11.9.1 Geron Corp Company Detail
11.9.2 Geron Corp Business Overview
11.9.3 Geron Corp Gene Therapy in Oncology Introduction
11.9.4 Geron Corp Revenue in Gene Therapy in Oncology Business (2019-2024)
11.9.5 Geron Corp Recent Development
11.10 Idera Pharmaceuticals
11.10.1 Idera Pharmaceuticals Company Detail
11.10.2 Idera Pharmaceuticals Business Overview
11.10.3 Idera Pharmaceuticals Gene Therapy in Oncology Introduction
11.10.4 Idera Pharmaceuticals Revenue in Gene Therapy in Oncology Business (2019-2024)
11.10.5 Idera Pharmaceuticals Recent Development
11.11 Intellia Therapeutics
11.11.1 Intellia Therapeutics Company Detail
11.11.2 Intellia Therapeutics Business Overview
11.11.3 Intellia Therapeutics Gene Therapy in Oncology Introduction
11.11.4 Intellia Therapeutics Revenue in Gene Therapy in Oncology Business (2019-2024)
11.11.5 Intellia Therapeutics Recent Development
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Detail
11.12.2 Johnson & Johnson Business Overview
11.12.3 Johnson & Johnson Gene Therapy in Oncology Introduction
11.12.4 Johnson & Johnson Revenue in Gene Therapy in Oncology Business (2019-2024)
11.12.5 Johnson & Johnson Recent Development
11.13 Marsala Biotech
11.13.1 Marsala Biotech Company Detail
11.13.2 Marsala Biotech Business Overview
11.13.3 Marsala Biotech Gene Therapy in Oncology Introduction
11.13.4 Marsala Biotech Revenue in Gene Therapy in Oncology Business (2019-2024)
11.13.5 Marsala Biotech Recent Development
11.14 Merck
11.14.1 Merck Company Detail
11.14.2 Merck Business Overview
11.14.3 Merck Gene Therapy in Oncology Introduction
11.14.4 Merck Revenue in Gene Therapy in Oncology Business (2019-2024)
11.14.5 Merck Recent Development
11.15 Mologen AG
11.15.1 Mologen AG Company Detail
11.15.2 Mologen AG Business Overview
11.15.3 Mologen AG Gene Therapy in Oncology Introduction
11.15.4 Mologen AG Revenue in Gene Therapy in Oncology Business (2019-2024)
11.15.5 Mologen AG Recent Development
11.16 Oncolytics Biotech
11.16.1 Oncolytics Biotech Company Detail
11.16.2 Oncolytics Biotech Business Overview
11.16.3 Oncolytics Biotech Gene Therapy in Oncology Introduction
11.16.4 Oncolytics Biotech Revenue in Gene Therapy in Oncology Business (2019-2024)
11.16.5 Oncolytics Biotech Recent Development
11.17 Oncosec
11.17.1 Oncosec Company Detail
11.17.2 Oncosec Business Overview
11.17.3 Oncosec Gene Therapy in Oncology Introduction
11.17.4 Oncosec Revenue in Gene Therapy in Oncology Business (2019-2024)
11.17.5 Oncosec Recent Development
11.18 Oncotelic
11.18.1 Oncotelic Company Detail
11.18.2 Oncotelic Business Overview
11.18.3 Oncotelic Gene Therapy in Oncology Introduction
11.18.4 Oncotelic Revenue in Gene Therapy in Oncology Business (2019-2024)
11.18.5 Oncotelic Recent Development
11.19 Shenzhen SiBiono GeneTech
11.19.1 Shenzhen SiBiono GeneTech Company Detail
11.19.2 Shenzhen SiBiono GeneTech Business Overview
11.19.3 Shenzhen SiBiono GeneTech Gene Therapy in Oncology Introduction
11.19.4 Shenzhen SiBiono GeneTech Revenue in Gene Therapy in Oncology Business (2019-2024)
11.19.5 Shenzhen SiBiono GeneTech Recent Development
11.20 Sillajen BiOthersapeutics
11.20.1 Sillajen BiOthersapeutics Company Detail
11.20.2 Sillajen BiOthersapeutics Business Overview
11.20.3 Sillajen BiOthersapeutics Gene Therapy in Oncology Introduction
11.20.4 Sillajen BiOthersapeutics Revenue in Gene Therapy in Oncology Business (2019-2024)
11.20.5 Sillajen BiOthersapeutics Recent Development
11.21 Tocagen
11.21.1 Tocagen Company Detail
11.21.2 Tocagen Business Overview
11.21.3 Tocagen Gene Therapy in Oncology Introduction
11.21.4 Tocagen Revenue in Gene Therapy in Oncology Business (2019-2024)
11.21.5 Tocagen Recent Development
11.22 UniQure
11.22.1 UniQure Company Detail
11.22.2 UniQure Business Overview
11.22.3 UniQure Gene Therapy in Oncology Introduction
11.22.4 UniQure Revenue in Gene Therapy in Oncology Business (2019-2024)
11.22.5 UniQure Recent Development
11.23 Ziopharm Oncology
11.23.1 Ziopharm Oncology Company Detail
11.23.2 Ziopharm Oncology Business Overview
11.23.3 Ziopharm Oncology Gene Therapy in Oncology Introduction
11.23.4 Ziopharm Oncology Revenue in Gene Therapy in Oncology Business (2019-2024)
11.23.5 Ziopharm Oncology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global Gene Therapy in Oncology Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Ex Vivo
Table 3. Key Players of In Vivo
Table 4. Global Gene Therapy in Oncology Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Gene Therapy in Oncology Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Gene Therapy in Oncology Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Gene Therapy in Oncology Market Share by Region (2019-2024)
Table 8. Global Gene Therapy in Oncology Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Gene Therapy in Oncology Market Share by Region (2025-2030)
Table 10. Gene Therapy in Oncology Market Trends
Table 11. Gene Therapy in Oncology Market Drivers
Table 12. Gene Therapy in Oncology Market Challenges
Table 13. Gene Therapy in Oncology Market Restraints
Table 14. Global Gene Therapy in Oncology Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Gene Therapy in Oncology Market Share by Players (2019-2024)
Table 16. Global Top Gene Therapy in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy in Oncology as of 2023)
Table 17. Ranking of Global Top Gene Therapy in Oncology Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Gene Therapy in Oncology Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Gene Therapy in Oncology Product Solution and Service
Table 21. Date of Enter into Gene Therapy in Oncology Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Gene Therapy in Oncology Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Gene Therapy in Oncology Revenue Market Share by Type (2019-2024)
Table 25. Global Gene Therapy in Oncology Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Gene Therapy in Oncology Revenue Market Share by Type (2025-2030)
Table 27. Global Gene Therapy in Oncology Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Gene Therapy in Oncology Revenue Market Share by Application (2019-2024)
Table 29. Global Gene Therapy in Oncology Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Gene Therapy in Oncology Revenue Market Share by Application (2025-2030)
Table 31. North America Gene Therapy in Oncology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Gene Therapy in Oncology Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Gene Therapy in Oncology Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Gene Therapy in Oncology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Gene Therapy in Oncology Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Gene Therapy in Oncology Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Gene Therapy in Oncology Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Gene Therapy in Oncology Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Gene Therapy in Oncology Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Gene Therapy in Oncology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Gene Therapy in Oncology Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Gene Therapy in Oncology Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Gene Therapy in Oncology Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Gene Therapy in Oncology Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Gene Therapy in Oncology Market Size by Country (2025-2030) & (US$ Million)
Table 46. Bristol-Myers Squibb Company Detail
Table 47. Bristol-Myers Squibb Business Overview
Table 48. Bristol-Myers Squibb Gene Therapy in Oncology Product
Table 49. Bristol-Myers Squibb Revenue in Gene Therapy in Oncology Business (2019-2024) & (US$ Million)
Table 50. Bristol-Myers Squibb Recent Development
Table 51. Cold Genesys Company Detail
Table 52. Cold Genesys Business Overview
Table 53. Cold Genesys Gene Therapy in Oncology Product
Table 54. Cold Genesys Revenue in Gene Therapy in Oncology Business (2019-2024) & (US$ Million)
Table 55. Cold Genesys Recent Development
Table 56. Advantagene Company Detail
Table 57. Advantagene Business Overview
Table 58. Advantagene Gene Therapy in Oncology Product
Table 59. Advantagene Revenue in Gene Therapy in Oncology Business (2019-2024) & (US$ Million)
Table 60. Advantagene Recent Development
Table 61. Amgen Company Detail
Table 62. Amgen Business Overview
Table 63. Amgen Gene Therapy in Oncology Product
Table 64. Amgen Revenue in Gene Therapy in Oncology Business (2019-2024) & (US$ Million)
Table 65. Amgen Recent Development
Table 66. AstraZeneca Company Detail
Table 67. AstraZeneca Business Overview
Table 68. AstraZeneca Gene Therapy in Oncology Product
Table 69. AstraZeneca Revenue in Gene Therapy in Oncology Business (2019-2024) & (US$ Million)
Table 70. AstraZeneca Recent Development
Table 71. Bio-Path Holdings Company Detail
Table 72. Bio-Path Holdings Business Overview
Table 73. Bio-Path Holdings Gene Therapy in Oncology Product
Table 74. Bio-Path Holdings Revenue in Gene Therapy in Oncology Business (2019-2024) & (US$ Million)
Table 75. Bio-Path Holdings Recent Development
Table 76. CRISPR Therapeutics Company Detail
Table 77. CRISPR Therapeutics Business Overview
Table 78. CRISPR Therapeutics Gene Therapy in Oncology Product
Table 79. CRISPR Therapeutics Revenue in Gene Therapy in Oncology Business (2019-2024) & (US$ Million)
Table 80. CRISPR Therapeutics Recent Development
Table 81. Editas Medicine Company Detail
Table 82. Editas Medicine Business Overview
Table 83. Editas Medicine Gene Therapy in Oncology Product
Table 84. Editas Medicine Revenue in Gene Therapy in Oncology Business (2019-2024) & (US$ Million)
Table 85. Editas Medicine Recent Development
Table 86. Geron Corp Company Detail
Table 87. Geron Corp Business Overview
Table 88. Geron Corp Gene Therapy in Oncology Product
Table 89. Geron Corp Revenue in Gene Therapy in Oncology Business (2019-2024) & (US$ Million)
Table 90. Geron Corp Recent Development
Table 91. Idera Pharmaceuticals Company Detail
Table 92. Idera Pharmaceuticals Business Overview
Table 93. Idera Pharmaceuticals Gene Therapy in Oncology Product
Table 94. Idera Pharmaceuticals Revenue in Gene Therapy in Oncology Business (2019-2024) & (US$ Million)
Table 95. Idera Pharmaceuticals Recent Development
Table 96. Intellia Therapeutics Company Detail
Table 97. Intellia Therapeutics Business Overview
Table 98. Intellia Therapeutics Gene Therapy in Oncology Product
Table 99. Intellia Therapeutics Revenue in Gene Therapy in Oncology Business (2019-2024) & (US$ Million)
Table 100. Intellia Therapeutics Recent Development
Table 101. Johnson & Johnson Company Detail
Table 102. Johnson & Johnson Business Overview
Table 103. Johnson & Johnson Gene Therapy in Oncology Product
Table 104. Johnson & Johnson Revenue in Gene Therapy in Oncology Business (2019-2024) & (US$ Million)
Table 105. Johnson & Johnson Recent Development
Table 106. Marsala Biotech Company Detail
Table 107. Marsala Biotech Business Overview
Table 108. Marsala Biotech Gene Therapy in Oncology Product
Table 109. Marsala Biotech Revenue in Gene Therapy in Oncology Business (2019-2024) & (US$ Million)
Table 110. Marsala Biotech Recent Development
Table 111. Merck Company Detail
Table 112. Merck Business Overview
Table 113. Merck Gene Therapy in Oncology Product
Table 114. Merck Revenue in Gene Therapy in Oncology Business (2019-2024) & (US$ Million)
Table 115. Merck Recent Development
Table 116. Mologen AG Company Detail
Table 117. Mologen AG Business Overview
Table 118. Mologen AG Gene Therapy in Oncology Product
Table 119. Mologen AG Revenue in Gene Therapy in Oncology Business (2019-2024) & (US$ Million)
Table 120. Mologen AG Recent Development
Table 121. Oncolytics Biotech Company Detail
Table 122. Oncolytics Biotech Business Overview
Table 123. Oncolytics Biotech Gene Therapy in Oncology Product
Table 124. Oncolytics Biotech Revenue in Gene Therapy in Oncology Business (2019-2024) & (US$ Million)
Table 125. Oncolytics Biotech Recent Development
Table 126. Oncosec Company Detail
Table 127. Oncosec Business Overview
Table 128. Oncosec Gene Therapy in Oncology Product
Table 129. Oncosec Revenue in Gene Therapy in Oncology Business (2019-2024) & (US$ Million)
Table 130. Oncosec Recent Development
Table 131. Oncotelic Company Detail
Table 132. Oncotelic Business Overview
Table 133. Oncotelic Gene Therapy in Oncology Product
Table 134. Oncotelic Revenue in Gene Therapy in Oncology Business (2019-2024) & (US$ Million)
Table 135. Oncotelic Recent Development
Table 136. Shenzhen SiBiono GeneTech Company Detail
Table 137. Shenzhen SiBiono GeneTech Business Overview
Table 138. Shenzhen SiBiono GeneTech Gene Therapy in Oncology Product
Table 139. Shenzhen SiBiono GeneTech Revenue in Gene Therapy in Oncology Business (2019-2024) & (US$ Million)
Table 140. Shenzhen SiBiono GeneTech Recent Development
Table 141. Sillajen BiOthersapeutics Company Detail
Table 142. Sillajen BiOthersapeutics Business Overview
Table 143. Sillajen BiOthersapeutics Gene Therapy in Oncology Product
Table 144. Sillajen BiOthersapeutics Revenue in Gene Therapy in Oncology Business (2019-2024) & (US$ Million)
Table 145. Sillajen BiOthersapeutics Recent Development
Table 146. Tocagen Company Detail
Table 147. Tocagen Business Overview
Table 148. Tocagen Gene Therapy in Oncology Product
Table 149. Tocagen Revenue in Gene Therapy in Oncology Business (2019-2024) & (US$ Million)
Table 150. Tocagen Recent Development
Table 151. UniQure Company Detail
Table 152. UniQure Business Overview
Table 153. UniQure Gene Therapy in Oncology Product
Table 154. UniQure Revenue in Gene Therapy in Oncology Business (2019-2024) & (US$ Million)
Table 155. UniQure Recent Development
Table 156. Ziopharm Oncology Company Detail
Table 157. Ziopharm Oncology Business Overview
Table 158. Ziopharm Oncology Gene Therapy in Oncology Product
Table 159. Ziopharm Oncology Revenue in Gene Therapy in Oncology Business (2019-2024) & (US$ Million)
Table 160. Ziopharm Oncology Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Gene Therapy in Oncology Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Gene Therapy in Oncology Market Share by Type: 2023 VS 2030
Figure 3. Ex Vivo Features
Figure 4. In Vivo Features
Figure 5. Global Gene Therapy in Oncology Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Gene Therapy in Oncology Market Share by Application: 2023 VS 2030
Figure 7. Hospitals Case Studies
Figure 8. Diagnostics Centers Case Studies
Figure 9. Research Institutes Case Studies
Figure 10. Gene Therapy in Oncology Report Years Considered
Figure 11. Global Gene Therapy in Oncology Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Gene Therapy in Oncology Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Gene Therapy in Oncology Market Share by Region: 2023 VS 2030
Figure 14. Global Gene Therapy in Oncology Market Share by Players in 2023
Figure 15. Global Top Gene Therapy in Oncology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy in Oncology as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Gene Therapy in Oncology Revenue in 2023
Figure 17. North America Gene Therapy in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Gene Therapy in Oncology Market Share by Country (2019-2030)
Figure 19. United States Gene Therapy in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Gene Therapy in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Gene Therapy in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Gene Therapy in Oncology Market Share by Country (2019-2030)
Figure 23. Germany Gene Therapy in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Gene Therapy in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Gene Therapy in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Gene Therapy in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Gene Therapy in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Gene Therapy in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Gene Therapy in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Gene Therapy in Oncology Market Share by Region (2019-2030)
Figure 31. China Gene Therapy in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Gene Therapy in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Gene Therapy in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Gene Therapy in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Gene Therapy in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Gene Therapy in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Gene Therapy in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Gene Therapy in Oncology Market Share by Country (2019-2030)
Figure 39. Mexico Gene Therapy in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Gene Therapy in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Gene Therapy in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Gene Therapy in Oncology Market Share by Country (2019-2030)
Figure 43. Turkey Gene Therapy in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Gene Therapy in Oncology Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Bristol-Myers Squibb Revenue Growth Rate in Gene Therapy in Oncology Business (2019-2024)
Figure 46. Cold Genesys Revenue Growth Rate in Gene Therapy in Oncology Business (2019-2024)
Figure 47. Advantagene Revenue Growth Rate in Gene Therapy in Oncology Business (2019-2024)
Figure 48. Amgen Revenue Growth Rate in Gene Therapy in Oncology Business (2019-2024)
Figure 49. AstraZeneca Revenue Growth Rate in Gene Therapy in Oncology Business (2019-2024)
Figure 50. Bio-Path Holdings Revenue Growth Rate in Gene Therapy in Oncology Business (2019-2024)
Figure 51. CRISPR Therapeutics Revenue Growth Rate in Gene Therapy in Oncology Business (2019-2024)
Figure 52. Editas Medicine Revenue Growth Rate in Gene Therapy in Oncology Business (2019-2024)
Figure 53. Geron Corp Revenue Growth Rate in Gene Therapy in Oncology Business (2019-2024)
Figure 54. Idera Pharmaceuticals Revenue Growth Rate in Gene Therapy in Oncology Business (2019-2024)
Figure 55. Intellia Therapeutics Revenue Growth Rate in Gene Therapy in Oncology Business (2019-2024)
Figure 56. Johnson & Johnson Revenue Growth Rate in Gene Therapy in Oncology Business (2019-2024)
Figure 57. Marsala Biotech Revenue Growth Rate in Gene Therapy in Oncology Business (2019-2024)
Figure 58. Merck Revenue Growth Rate in Gene Therapy in Oncology Business (2019-2024)
Figure 59. Mologen AG Revenue Growth Rate in Gene Therapy in Oncology Business (2019-2024)
Figure 60. Oncolytics Biotech Revenue Growth Rate in Gene Therapy in Oncology Business (2019-2024)
Figure 61. Oncosec Revenue Growth Rate in Gene Therapy in Oncology Business (2019-2024)
Figure 62. Oncotelic Revenue Growth Rate in Gene Therapy in Oncology Business (2019-2024)
Figure 63. Shenzhen SiBiono GeneTech Revenue Growth Rate in Gene Therapy in Oncology Business (2019-2024)
Figure 64. Sillajen BiOthersapeutics Revenue Growth Rate in Gene Therapy in Oncology Business (2019-2024)
Figure 65. Tocagen Revenue Growth Rate in Gene Therapy in Oncology Business (2019-2024)
Figure 66. UniQure Revenue Growth Rate in Gene Therapy in Oncology Business (2019-2024)
Figure 67. Ziopharm Oncology Revenue Growth Rate in Gene Therapy in Oncology Business (2019-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock